157 related articles for article (PubMed ID: 10800876)
1. Does high dose ipratropium bromide added to salbutamol improve pulmonary function for patients with chronic obstructive airways disease in the emergency department?
Koutsogiannis Z; Kelly AM
Aust N Z J Med; 2000 Feb; 30(1):38-40. PubMed ID: 10800876
[TBL] [Abstract][Full Text] [Related]
2. Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials.
Haney S; Hancox RJ
Respir Res; 2007 Mar; 8(1):19. PubMed ID: 17341317
[TBL] [Abstract][Full Text] [Related]
3. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials.
Lanes SF; Garrett JE; Wentworth CE; Fitzgerald JM; Karpel JP
Chest; 1998 Aug; 114(2):365-72. PubMed ID: 9726716
[TBL] [Abstract][Full Text] [Related]
4. The combination of ipratropium and albuterol optimizes pulmonary function reversibility testing in patients with COPD.
Dorinsky PM; Reisner C; Ferguson GT; Menjoge SS; Serby CW; Witek TJ
Chest; 1999 Apr; 115(4):966-71. PubMed ID: 10208193
[TBL] [Abstract][Full Text] [Related]
5. Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease.
Colice GL
Am J Med; 1996 Jan; 100(1A):11S-18S. PubMed ID: 8610712
[TBL] [Abstract][Full Text] [Related]
6. In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium : a 3-week, randomized, double-blind, within-patient, multicenter study.
D'Urzo AD; De Salvo MC; Ramirez-Rivera A; Almeida J; Sichletidis L; Rapatz G; Kottakis J;
Chest; 2001 May; 119(5):1347-56. PubMed ID: 11348938
[TBL] [Abstract][Full Text] [Related]
7. Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.
Moayyedi P; Congleton J; Page RL; Pearson SB; Muers MF
Thorax; 1995 Aug; 50(8):834-7. PubMed ID: 7570433
[TBL] [Abstract][Full Text] [Related]
8. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction.
O'Driscoll BR; Taylor RJ; Horsley MG; Chambers DK; Bernstein A
Lancet; 1989 Jun; 1(8652):1418-20. PubMed ID: 2567431
[TBL] [Abstract][Full Text] [Related]
9. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
Jarvis B; Markham A
Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
[TBL] [Abstract][Full Text] [Related]
10. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
[TBL] [Abstract][Full Text] [Related]
11. Relative and additional bronchodilator response of salbutamol and ipratropium in smoker and nonsmoker asthmatics.
Ahmad Z; Singh SK
J Asthma; 2010 Apr; 47(3):340-3. PubMed ID: 20394521
[TBL] [Abstract][Full Text] [Related]
12. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department.
Rodrigo GJ; Rodrigo C
Am J Respir Crit Care Med; 2000 Jun; 161(6):1862-8. PubMed ID: 10852758
[TBL] [Abstract][Full Text] [Related]
13. Comparison of nebulized ipratropium bromide with salbutamol vs salbutamol alone in acute asthma exacerbation in children.
Watanasomsiri A; Phipatanakul W
Ann Allergy Asthma Immunol; 2006 May; 96(5):701-6. PubMed ID: 16729783
[TBL] [Abstract][Full Text] [Related]
14. Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone.
Ikeda A; Nishimura K; Koyama H; Izumi T
Chest; 1995 Feb; 107(2):401-5. PubMed ID: 7842768
[TBL] [Abstract][Full Text] [Related]
15. Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD.
Cazzola M; Santus P; D'Adda A; Pizzolato S; Di Marco F; Centanni S
Pulm Pharmacol Ther; 2009 Jun; 22(3):177-82. PubMed ID: 19038356
[TBL] [Abstract][Full Text] [Related]
16. Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease.
Burdet L; de Muralt B; Schutz Y; Fitting JW
Thorax; 1997 Feb; 52(2):130-5. PubMed ID: 9059472
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind, placebo-controlled trial of intravenous salbutamol and nebulized ipratropium bromide in early management of severe acute asthma in children presenting to an emergency department.
Browne GJ; Trieu L; Van Asperen P
Crit Care Med; 2002 Feb; 30(2):448-53. PubMed ID: 11889328
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD.
Friedman M; Serby CW; Menjoge SS; Wilson JD; Hilleman DE; Witek TJ
Chest; 1999 Mar; 115(3):635-41. PubMed ID: 10084468
[TBL] [Abstract][Full Text] [Related]
19. The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD.
Singh D; Abbott-Banner K; Bengtsson T; Newman K
Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30166326
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease.
Matera MG; Cazzola M; Vinciguerra A; Di Perna F; Calderaro F; Caputi M; Rossi F
Pulm Pharmacol; 1995 Dec; 8(6):267-71. PubMed ID: 8819181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
